311
Views
11
CrossRef citations to date
0
Altmetric
Reviews

The reduction of melatonin levels is associated with the development of preeclampsia: a meta-analysis

, , , , , & show all
Pages 65-72 | Received 12 Oct 2018, Accepted 06 Feb 2019, Published online: 22 Feb 2019
 

ABSTRACT

Objective: The aim of this analysis was to demonstrate the association between melatonin levels and the development of preeclampsia.

Methods: Standardized mean difference (SMD) with 95% confidence interval (CI) was calculated using a random effects model.

Results: The pooled SMD between case and control was 1.40 (95% CI: 0.26, 2.55; P = 0.02). And the pooled SMD between mild PE and severe PE was 5.25 (95% CI: 1.5, 9.01; P = 0.006).

Conclusion: The meta-analysis illustrated that melatonin concentration was significantly lower in women with preeclampsia, and correlated with the severity of the disease.

Acknowledgments

The authors would like to thank Professor Lu for his guidance and instructive advice.

Disclosure statement

No potential conflict of interest was reported by the authors.

Supplementary material

Supplemental data can be accessed here.

Additional information

Funding

This work was supported by the the University Science Research Project of Jiangsu Province [16KJB330009]; the Chinese National Nature Science Foundation [81473008, 81673203, 81803271, 81573173, 81402626].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.